![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
D Fau, D Eugene, A Berson, P Letteron, B Fromenty, C Fisch and D Pessayre
Institut National de la Sante et de la Recherche Medicale Unite 24 (INSERM U-24), Hopital Beaujon, Clichy, France.
The hepatotoxicity of flutamide, an antiandrogen that produces hepatitis in some human recipients, was studied in isolated rat hepatocytes. Flutamide (1 mM) led to the covalent binding of reactive electrophilic metabolites to male rat hepatocyte proteins. It decreased the reduced glutathione (GSH)/glutathione disulfide ratio and total protein thiols. This was associated with an early increase in phosphorylase a activity (a Ca(++)-dependent enzyme) and a decrease in cytoskeleton-associated protein thiols, the formation of plasma membrane blebs, the release of lactate dehydrogenase (LDH) and a loss of cell viability. Both covalent binding and LDH release were decreased by piperonyl butoxide (an inhibitor of cytochrome P450) and increased by dexamethasone pretreatment (which induces cytochrome P450 3A). The toxicity was increased by beta-naphthoflavone (which induces cytochrome P450 1A). Hepatocytes from female rats (which lack cytochrome P450 3A2) exhibited lower covalent binding and lower LDH release. The addition of cystine (a GSH precursor) increased hepatocellular GSH and decreased LDH release in male hepatocytes. The administration of a diet deficient in sulfur-containing amino acids had the opposite effects; it produced toxicity with 100 microM flutamide. Flutamide (50 microM) markedly inhibited respiration (mainly at the level of complex I) in isolated male rat liver mitochondria and flutamide (1 mM) decreased ATP levels in isolated male rat hepatocytes. It was concluded that flutamide is toxic to rat hepatocytes as a result of the cytochrome P450 (3A and also 1A)-mediated formation of electrophilic metabolites, whose damaging effects are further aggravated by the inhibitory effect of flutamide on mitochondrial respiration and ATP formation.
This article has been cited by other articles:
|
|
 |
|
  P. Kang, D. Dalvie, E. Smith, S. Zhou, A. Deese, and J. A. Nieman Bioactivation of Flutamide Metabolites by Human Liver Microsomes Drug Metab. Dispos., July 1, 2008; 36(7): 1425 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kang, D. Dalvie, E. Smith, S. Zhou, and A. Deese Identification of a Novel Glutathione Conjugate of Flutamide in Incubations with Human Liver Microsomes Drug Metab. Dispos., July 1, 2007; 35(7): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Scatena, P. Bottoni, G. Botta, G. E. Martorana, and B. Giardina The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic Am J Physiol Cell Physiol, July 1, 2007; 293(1): C12 - C21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Marroquin, J. Hynes, J. A. Dykens, J. D. Jamieson, and Y. Will Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants Toxicol. Sci., June 1, 2007; 97(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Coe, S. D. Nelson, R. G. Ulrich, Y. He, X. Dai, O. Cheng, M. Caguyong, C. J. Roberts, and J. G. Slatter PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS Drug Metab. Dispos., July 1, 2006; 34(7): 1266 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hynes, L. D. Marroquin, V. I. Ogurtsov, K. N. Christiansen, G. J. Stevens, D. B. Papkovsky, and Y. Will Investigation of Drug-Induced Mitochondrial Toxicity Using Fluorescence-Based Oxygen-Sensitive Probes Toxicol. Sci., July 1, 2006; 92(1): 186 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tevell, H. Lennernas, M. Jonsson, M. Norlin, B. Lennernas, U. Bondesson, and M. Hedeland FLUTAMIDE METABOLISM IN FOUR DIFFERENT SPECIES IN VITRO AND IDENTIFICATION OF FLUTAMIDE METABOLITES IN HUMAN PATIENT URINE BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY Drug Metab. Dispos., June 1, 2006; 34(6): 984 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Goda, D. Nagai, Y. Akiyama, K. Nishikawa, I. Ikemoto, Y. Aizawa, K. Nagata, and Y. Yamazoe DETECTION OF A NEW N-OXIDIZED METABOLITE OF FLUTAMIDE, N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]HYDROXYLAMINE, IN HUMAN LIVER MICROSOMES AND URINE OF PROSTATE CANCER PATIENTS Drug Metab. Dispos., May 1, 2006; 34(5): 828 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hero, O. A. Janne, K. Nanto-Salonen, L. Dunkel, and T. Raivio Circulating Antiandrogenic Activity in Children with Congenital Adrenal Hyperplasia during Peroral Flutamide Treatment J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5141 - 5145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Berson, V. Descatoire, A. Sutton, D. Fau, B. Maulny, N. Vadrot, G. Feldmann, B. Berthon, T. Tordjmann, and D. Pessayre Toxicity of Alpidem, a Peripheral Benzodiazepine Receptor Ligand, but Not Zolpidem, in Rat Hepatocytes: Role of Mitochondrial Permeability Transition and Metabolic Activation J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 793 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cetin, D. Demirci, A. Unal, M. Altinbas, M. Guven, and K. Unluhizarci Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma Human and Experimental Toxicology, March 1, 1999; 18(3): 137 - 140. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Shet, M. McPhaul, C. W. Fisher, N. R. Stallings, and R. W. Estabrook Metabolism of the Antiandrogenic Drug (Flutamide) by Human CYP1A2 Drug Metab. Dispos., November 1, 1997; 25(11): 1298 - 1303. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
